Ulrich Kleeberg

Author PubWeight™ 5.44^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer.	Breast Cancer Res Treat	2005	1.53
2	Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.	J Clin Oncol	2005	1.36
3	Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer.	Oncology	2006	0.92
4	User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center.	Anticancer Res	2014	0.87
5	Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.	Oncology	2005	0.85